期刊文献+

柱前衍生化HPLC法测定注射用氨磷汀的含量 被引量:2

HPLC method using pre-column derivatization for determinating the content of amifostine
下载PDF
导出
摘要 目的建立一种测定注射用氨磷汀含量的HPLC法。方法氨磷汀经氯甲酸芴甲酯(9-fluorenylmethylchloroformate,FMOC-Cl)衍生化后用HPLC法分析。采用Agilent C18柱(150 mm×4.6 mm,5μm)色谱柱,流动相A:乙腈,B:水。0~4 min,A∶B=30∶70;4.1~10 min,A∶B=98∶2,每次进样前再平衡7 min;柱温25℃,流速1 mL/min,检测波长265 nm。外标法计算含量。结果在该色谱条件下,氨磷汀在5~100μg/mL浓度范围内有良好的线性关系(r>0.999,n=6),回收率为97%~103%(n=5),RSD<2.0%(n=5)。最低检测质量浓度为100 ng/mL。样品在6 h内稳定。测得样品含量合格,在90%~110%之间。结论经方法学实验验证,该方法简便、快速、结果准确、可靠、重现性好。 Objective To establish a HPLC method for the determination of amifostine. Methods 9-fluorenylmethyl chloroformate (FMOC-C1) was used for derivatization. An agilent C,s column (4.6 mm 150 ram, 5 l,m) was adopted as stationary phase. Elution was carried out with acetonitrile (solvent A) and water (solvent B) at a flow-rate of 1 mI./min. Gradient HPLC was used with the solvent ratio changed from 30:70 (for 4 rain) to 98:2 (from 4. 1 rain to 10 min) for solvent A:B, respectively,and the rebalancing time was 7 rain. The detection wavelength was 265 nm and the temperature of column was 25℃. Results Amifostine had a good linearity (r〉0. 999,n = 6) in the range of 5 - 100 μg/mL. The recovery values were between 97% and 103% ,RSD(2. 0% (n = 3). The detection limit value was 100 ng/mL. The samples were stable in 6 hour and qualified between 90% and 110%. Conclusions The method was proved to be accurate, sensitive and reliable.
出处 《复旦学报(医学版)》 CAS CSCD 北大核心 2013年第1期60-62,共3页 Fudan University Journal of Medical Sciences
基金 复旦大学附属眼耳鼻喉科医院院级基金项目(EENT-2010-1F) 上海市浦东新区卫生局卫生科技项目(PW2009D-7) 上海市科学技术委员会医学引导类项目(09411962000)~~
关键词 高效液相色谱法 氨磷汀 注射用氨磷汀 HPLC amifostine amifostine for injection
  • 相关文献

参考文献5

  • 1Kouvaris JR. Kouloulias VE, Vlahos LJ. Amifostine: TheFirst Selcctive-Target and Broad-Spectrum Radioprotector[J]. The2007,12(6) :738 - 747.
  • 2Bai F- Kirstein MN,Hanna SK, et al. New liquidchromatographic assay with electrochemical detection forthe measurement of amifostine and WR1065 [J]. JChromatogr B Analyt Technol Biomed Life Sci. 2002 ,772?2):257 - 265.
  • 3Bolner A, Barbato L, Tagliaro P', et al. Determination ofapomorphine in human plasma by ?ilumina extraction andhigh-performance liquid chromatography withelectrochemical detection [J]. Forejisic Sci Int,1997,89( 1-2):81 -01.
  • 4郁丰善,蔡苹,陈芳.化学发光法测定氨磷汀研究[J].分析科学学报,2008,24(2):149-152. 被引量:2
  • 5孙伟光,卢婷利,陈涛,于洋.高效液相色谱-荧光胺柱前衍生法测定氨磷汀微球中氨磷汀的含量[J].中国医院药学杂志,2009,29(14):1189-1192. 被引量:2

二级参考文献18

  • 1齐剑英,李祥平,冯德雄,杨培慧.应用新荧光增强剂荧光胺测定GSH[J].分析试验室,2004,23(12):85-87. 被引量:3
  • 2潘莹宇,张建新,许茜.荧光衍生化法测定牛奶中氯霉素残留的研究[J].分析试验室,2005,24(5):67-70. 被引量:18
  • 3John R. Kouvaris, Vassilis E, Kouloulias, etal. Amifostine: The First Selective-Target and Broad-Spectrum Radioprotector [J]. The Oncologist, 2007, 12: 738.
  • 4Bai F, Kirstein MN, Hanna SK, et al. New liquid chromatographic assay with electrochemical detection for the measurement of amifostine and WR1065[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2002 ,772(2) : 257.
  • 5中国药典.二部[S].2005.附录:29.
  • 6Lawrence T S,Robertson J M,Anscher M S,Jirtle R L,Ensminger W D,Fajardo L F.Int.J.Radiat.Oncol.Biol.Phys.[J],1995,31(5):1237.
  • 7Culy C R,Spencer C M.Drugs[J],2001,61:641.
  • 8Swynnerton N F,McGovern E P,Nino J A,Mangold D J.Int.J.Radiat.Oncol.Biol.Phys.[J],1984,10:1521.
  • 9Fahey R C,Newton G L.Int.J.Radiat.Oncol.Biol.Phys.[J],1985,11:1193.
  • 10Utley J F,Seaver N,Newton G L,Fahey R C.Int.J.Radiat.Oncol.Biol.Phys.[J],1984,10:1525.

共引文献1

同被引文献23

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部